Keywords: Impax Pharma, GlaxoSmithKline, IPX066, Ph III, Parkinson's disease

Positive top-line Ph III results of Impax and GSK IPX066 in advanced Parkinson’s disease

Article | 16 August 2011

USA-based Impax Pharmaceuticals, the branded products division of Impax Laboratories, (Nasdaq: IPXL), and UK drugs giant GlaxoSmithKline (LSE: GSK) have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

Impax Laboratories

Go to company listing